title: Prognostic impact of ACE inhibition in systemic lupus erythematosus, diabetes mellitus and chronic glomerulonephritis.
authors.affiliation: Department of Nephrology, Sahlgrenska Sjukhuset, University of Göteborg, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Aurell
authors.forename: O
authors.initials: O
authors.lastname: Samuelsson
authors.forename: P O
authors.initials: PO
authors.lastname: Attman
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002908:Chronic Disease; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000503:physiopathology; D011379:Prognosis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors